Disruption of integrin-dependent adhesion and survival of endothelial cells by recombinant adenovirus expressing isolated β integrin cytoplasmic domains

[1]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[2]  R. Soldi,et al.  Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2 , 1999, The EMBO journal.

[3]  P. Oettgen,et al.  Role of Ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  M. Humphries,et al.  Amino acid motifs required for isolated beta cytoplasmic domains to regulate 'in trans' beta1 integrin conformation and function in cell attachment. , 1999, Journal of cell science.

[5]  R. Hynes,et al.  Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv Integrins , 1998, Cell.

[6]  G. Bieler,et al.  Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γ , 1998, Nature Medicine.

[7]  D. Cheresh,et al.  Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity , 1998, Cell.

[8]  M. Detmar,et al.  Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Thomas Boehm,et al.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.

[10]  H. Krell,et al.  β1 Integrin Is Essential for Teratoma Growth and Angiogenesis , 1997, The Journal of cell biology.

[11]  A. Mastrangelo,et al.  Integrin cytoplasmic domains as connectors to the cell's signal transduction apparatus. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[12]  Ulrich Keilholz,et al.  Immunohistochemical analysis of integrin αvβ3 expression on tumor‐associated vessels of human carcinomas , 1997 .

[13]  L. Singh,et al.  The Role of Conserved Amino Acid Motifs within the Integrin β3 Cytoplasmic Domain in Triggering Focal Adhesion Kinase Phosphorylation* , 1997, The Journal of Biological Chemistry.

[14]  D. Cheresh,et al.  Cell adhesion and angiogenesis. , 1996, Trends in cell biology.

[15]  M. Ginsberg,et al.  Trans-dominant inhibition of integrin function. , 1996, Molecular biology of the cell.

[16]  P. Brooks,et al.  Role of integrins in angiogenesis. , 1996, European journal of cancer.

[17]  S. Dedhar,et al.  Integrin cytoplasmic interactions and bidirectional transmembrane signalling. , 1996, Current opinion in cell biology.

[18]  J. Becker,et al.  Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. , 1996, The Journal of clinical investigation.

[19]  W. Stetler-Stevenson,et al.  Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.

[20]  C. Cabañas,et al.  Activated Conformations of Very Late Activation Integrins Detected by a Group of Antibodies (HUTS) Specific for a Novel Regulatory Region(355425) of the Common 1 Chain (*) , 1996, The Journal of Biological Chemistry.

[21]  D. Hanahan,et al.  Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  David A. Cheresh,et al.  Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.

[23]  F. Sarkar,et al.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.

[24]  K. Alitalo,et al.  Endothelial-specific gene expression directed by the tie gene promoter in vivo. , 1995, Blood.

[25]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[26]  C. Damsky,et al.  Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo , 1995, The Journal of cell biology.

[27]  D. Cheresh,et al.  An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. , 1995, Journal of cell science.

[28]  J. Schaack,et al.  Efficient selection of recombinant adenoviruses by vectors that express beta-galactosidase , 1995, Journal of virology.

[29]  C. Gahmberg,et al.  Mutation of the cytoplasmic domain of the integrin beta 3 subunit. Differential effects on cell spreading, recruitment to adhesion plaques, endocytosis, and phagocytosis. , 1995, The Journal of biological chemistry.

[30]  R. Hynes,et al.  Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development. , 1995, Development.

[31]  D. Cheresh,et al.  Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.

[32]  L. Smilenov,et al.  Integrin beta 1 cytoplasmic domain dominant negative effects revealed by lysophosphatidic acid treatment. , 1994, Molecular biology of the cell.

[33]  F. Re,et al.  Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells , 1994, The Journal of cell biology.

[34]  K. Yamada,et al.  Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin functions in receptor localization, cell spreading and migration, and matrix assembly , 1994, The Journal of cell biology.

[35]  D. Sheppard,et al.  Disruption of integrin function and induction of tyrosine phosphorylation by the autonomously expressed beta 1 integrin cytoplasmic domain. , 1994, The Journal of biological chemistry.

[36]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[37]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[38]  R. Hynes,et al.  Embryonic mesodermal defects in alpha 5 integrin-deficient mice. , 1993, Development.

[39]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[40]  Kenneth M. Yamada,et al.  Regulation of fibronectin receptor distribution [published erratum appears in J Cell Biol 1992 Jul;118(2):491] , 1992, The Journal of cell biology.

[41]  R. Eisman,et al.  Structure of platelet glycoprotein IIIa. A common subunit for two different membrane receptors. , 1988, The Journal of clinical investigation.

[42]  S. Timmons,et al.  Identification of a functionally important sequence in the cytoplasmic tail of integrin f33 by using cell-permeable peptide analogs , 2005 .

[43]  K. Yamada,et al.  Regulation of Fibronectin Receptor Distribution , 2002 .

[44]  G. Bieler,et al.  Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. , 1998, Nature medicine.

[45]  D. Ruiter,et al.  Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. , 1997, International journal of cancer.

[46]  W. Stetler-Stevenson,et al.  Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. , 1996, Cell.

[47]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[48]  T. Idziorek,et al.  YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. , 1995, Journal of immunological methods.

[49]  D. Cheresh,et al.  Definition of two angiogenic pathways by distinct alpha v integrins. , 1995, Science.

[50]  D. Cheresh,et al.  Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. , 1994, Cell.

[51]  C. Newgard,et al.  Use of recombinant adenovirus for metabolic engineering of mammalian cells. , 1994, Methods in cell biology.